American Capital Management Inc. Has $19.05 Million Holdings in STAAR Surgical (NASDAQ:STAA)

American Capital Management Inc. boosted its stake in STAAR Surgical (NASDAQ:STAA) by 42.9% in the third quarter, HoldingsChannel.com reports. The firm owned 512,813 shares of the medical instruments supplier’s stock after buying an additional 154,037 shares during the period. American Capital Management Inc.’s holdings in STAAR Surgical were worth $19,051,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of STAA. Arcadia Investment Management Corp MI bought a new stake in shares of STAAR Surgical in the 3rd quarter valued at about $37,000. Quest Partners LLC bought a new stake in STAAR Surgical in the third quarter valued at approximately $128,000. Canada Pension Plan Investment Board bought a new stake in STAAR Surgical in the second quarter valued at approximately $129,000. Van ECK Associates Corp increased its position in STAAR Surgical by 12.7% during the 3rd quarter. Van ECK Associates Corp now owns 3,478 shares of the medical instruments supplier’s stock valued at $129,000 after purchasing an additional 393 shares during the period. Finally, Larson Financial Group LLC bought a new position in STAAR Surgical during the 2nd quarter worth approximately $130,000. 96.70% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Stifel Nicolaus decreased their price objective on shares of STAAR Surgical from $50.00 to $44.00 and set a “buy” rating for the company in a research report on Monday, August 26th. Canaccord Genuity Group lowered their price objective on shares of STAAR Surgical from $41.00 to $31.00 and set a “hold” rating for the company in a research note on Friday, November 1st. Finally, Needham & Company LLC reissued a “hold” rating on shares of STAAR Surgical in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $43.33.

STAAR Surgical Trading Up 3.3 %

STAAR Surgical stock opened at $29.10 on Friday. The firm’s fifty day moving average price is $30.58 and its two-hundred day moving average price is $36.16. The firm has a market capitalization of $1.43 billion, a price-to-earnings ratio of 66.14 and a beta of 0.61. STAAR Surgical has a 1-year low of $25.88 and a 1-year high of $52.68.

STAAR Surgical Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.